{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:13:27Z","timestamp":1793225607481,"version":"4.5.0"},"reference-count":122,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Protease-activated receptor 2 (PAR2) is a cell-surface receptor expressed in various cell types, including keratinocytes, neurons, immune and inflammatory cells. Activation of PAR2, whether via its canonical or biased pathways, triggers a series of signaling cascades that mediate numerous functions. This review aims to highlight the emerging roles and interactions of PAR2 in different skin cells. It specifically summarizes the latest insights into the roles of PAR2 in skin conditions such as atopic dermatitis (AD), psoriasis, vitiligo and melasma. It also considers these roles from the perspective of the cutaneous microenvironment in relation to other inflammatory and autoimmune dermatological disorders. Additionally, the review explores PAR2\u2019s involvement in associated comorbidities from both cutaneous and extracutaneous diseases. Therefore, PAR2 may serve as a key target for interactions among various cells within the local skin environment.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1449126","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:30:50Z","timestamp":1726705850000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Update on protease-activated receptor 2 in inflammatory and autoimmune dermatological diseases"],"prefix":"10.3389","volume":"15","author":[{"given":"Kejia","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.20.9208","article-title":"Molecular cloning of a potential proteinase activated receptor","volume":"91","author":"Nystedt","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3892\/ijmm.2016.2464","article-title":"Evolution of the protease-activated receptor family in vertebrates","volume":"37","author":"Jin","year":"2016","journal-title":"Int J Mol Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.070347","article-title":"Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation","volume":"172","author":"Borensztajn","year":"2008","journal-title":"Am J Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-1745","article-title":"Membrane-anchored serine proteases and protease-activated receptor-2-mediated signaling: co-conspirators in cancer progression","volume":"79","author":"Pawar","year":"2019","journal-title":"Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.2.1014","article-title":"Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells","volume":"167","author":"Sun","year":"2001","journal-title":"J Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/all.12827","article-title":"Cockroach allergen exposure and risk of asthma","volume":"71","author":"Do","year":"2016","journal-title":"Allergy"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00044.2021","article-title":"Protease-activated receptors in health and disease","volume":"103","author":"Peach","year":"2023","journal-title":"Physiol Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1358\/dnp.2008.21.7.1255294","article-title":"Proteinase-activated receptor-2 in the skin: receptor expression, activation and function during health and disease","volume":"21","author":"Rattenholl","year":"2008","journal-title":"Drug News Perspect"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13936","article-title":"Update on protease-activated receptor 2 in cutaneous barrier, differentiation, tumorigenesis and pigmentation, and its role in related dermatologic diseases","volume":"28","author":"Henehan","year":"2019","journal-title":"Exp Dermatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.1999.tb00383.x","article-title":"Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase","volume":"8","author":"Steinhoff","year":"1999","journal-title":"Exp Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.celrep.2019.03.053","article-title":"PAR2-mediated cAMP generation suppresses TRPV4-dependent ca2+ Signaling in alveolar macrophages to resolve TLR4-induced inflammation","volume":"27","author":"Rayees","year":"2019","journal-title":"Cell Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2016.28.6.771","article-title":"Protease-activated receptor-2: A multifaceted molecular transducer in the human skin","volume":"28","author":"Andersen","year":"2016","journal-title":"Ann Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00067","article-title":"Biased signaling of protease-activated receptors","volume":"5","author":"Zhao","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1523\/JNEUROSCI.1211-20.2020","article-title":"Legumain induces oral cancer pain by biased agonism of protease-activated receptor-2","volume":"41","author":"Tu","year":"2021","journal-title":"J Neurosci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.006935","article-title":"Protein kinase D and G\u03b2\u03b3 mediate sustained nociceptive signaling by biased agonists of protease-activated receptor-2","volume":"294","author":"Zhao","year":"2019","journal-title":"J Biol Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12544","article-title":"Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease","volume":"171","author":"Hollenberg","year":"2014","journal-title":"Br J Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2004-0274OC","article-title":"Pseudomonas aeruginosa elastase disables proteinase-activated receptor 2 in respiratory epithelial cells","volume":"32","author":"Dulon","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.874197","article-title":"Protease-activated receptor 2 promotes clearance of Pseudomonas aeruginosa infection by inducing cAMP-Rac1 signaling in alveolar macrophages","volume":"13","author":"Rayees","year":"2022","journal-title":"Front Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nature22309","article-title":"Structural insight into allosteric modulation of protease-activated receptor 2","volume":"545","author":"Cheng","year":"2017","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e2452","DOI":"10.1038\/cddis.2016.357","article-title":"PAR2 regulates regeneration, transdifferentiation, and death","volume":"7","author":"Piran","year":"2016","journal-title":"Cell Death Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.7.4043","article-title":"Interactions of mast cell tryptase with thrombin receptors and PAR-2","volume":"272","author":"Molino","year":"1997","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.070","article-title":"Glycosylation and the activation of proteinase-activated receptor 2 (PAR(2)) by human mast cell tryptase","volume":"134","author":"Compton","year":"2001","journal-title":"Br J Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702834","article-title":"Proteinase activated receptor 2: Role of extracellular loop 2 for ligand-mediated activation","volume":"128","author":"Al-Ani","year":"1999","journal-title":"Br J Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1124\/mol.109.055509PMC2769049","article-title":"Agonist-biased signaling via proteinase activated receptor-2: differential activation of calcium and mitogen-activated protein kinase pathways","volume":"76","author":"Ramachandran","year":"2009","journal-title":"Mol Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.10.018","article-title":"PAR2 triggers IL-8 release via MEK\/ERK and PI3-kinase\/Akt pathways in GI epithelial cells","volume":"377","author":"Tanaka","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1721891115","article-title":"Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome","volume":"115","author":"Jimenez-Vargas","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.089490","article-title":"Signal transduction for proteinase-activated receptor-2-triggered prostaglandin E2 formation in human lung epithelial cells","volume":"315","author":"Kawao","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.625289","article-title":"Targeting PAR2 overcomes gefitinib resistance in non-small-cell lung cancer cells through inhibition of EGFR transactivation","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp153","article-title":"Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion","volume":"30","author":"Kaufmann","year":"2009","journal-title":"Carcinogenesis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2006.111534","article-title":"Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon and A-dependent mechanisms in rats and mice","volume":"575","author":"Amadesi","year":"2006","journal-title":"J Physiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12750","article-title":"The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo","volume":"171","author":"Grace","year":"2014","journal-title":"Br J Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12974-017-0916-4","article-title":"Sensitization of ASIC3 by proteinase-activated receptor 2 signaling contributes to acidosis-induced nociception","volume":"14","author":"Wu","year":"2017","journal-title":"J Neuroinflamm"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.692640","article-title":"Protease-activated receptor-2 (PAR-2)-mediated NF-\u03baB activation suppresses inflammation-associated tumor suppressor microRNAs in oral squamous cell carcinoma","volume":"291","author":"Johnson","year":"2016","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/72247","article-title":"Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism","volume":"6","author":"Steinhoff","year":"2000","journal-title":"Nat Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.048942","article-title":"Phosphorylation of protease-activated receptor-2 differentially regulates desensitization and internalization","volume":"284","author":"Ricks","year":"2009","journal-title":"J Biol Chem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2013.00196","article-title":"Interaction of protease-activated receptor 2 with G proteins and \u03b2-arrestin 1 studied by bioluminescence resonance energy transfer","volume":"4","author":"Ayoub","year":"2013","journal-title":"Front Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.26.18524","article-title":"Trafficking of proteinase-activated receptor-2 and \u03b2-arrestin-1 tagged with green fluorescent protein","volume":"274","author":"Dery","year":"1999","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e2112059119","DOI":"10.1073\/pnas.2112059119","article-title":"Mice expressing fluorescent PAR(2) reveal that endocytosis mediates colonic inflammation and pain","volume":"119","author":"Latorre","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M702974200","article-title":"Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) mediates post-endocytic trafficking of protease-activated receptor 2 and calcitonin receptor-like receptor","volume":"282","author":"Hasdemir","year":"2007","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.710681","article-title":"Protein kinase D and G\u03b2\u03b3 subunits mediate agonist-evoked translocation of protease-activated receptor-2 from the golgi apparatus to the plasma membrane","volume":"291","author":"Jensen","year":"2016","journal-title":"J Biol Chem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-768218","article-title":"Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling","volume":"131","author":"Rothmeier","year":"2018","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2461","article-title":"Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation","volume":"17","author":"Badeanlou","year":"2011","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472","article-title":"Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice","volume":"68","author":"Versteeg","year":"2008","journal-title":"Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700351","article-title":"Serine protease signaling of epidermal permeability barrier homeostasis","volume":"126","author":"Hachem","year":"2006","journal-title":"J Invest Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0177(200007)218:3<465::AID-DVDY1013>3.0.CO;2-5","article-title":"Expression of protease-activated receptor-2 during embryonic development","volume":"218","author":"Jenkins","year":"2000","journal-title":"Dev Dyn"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2010.11.016","article-title":"Actin dynamics regulate immediate PAR-2-dependent responses to acute epidermal permeability barrier abrogation","volume":"61","author":"Roelandt","year":"2011","journal-title":"J Dermatol Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.01.003","article-title":"Protease activity enhances production of thymic stromal lymphopoietin and basophil accumulation in flaky tail mice","volume":"182","author":"Moniaga","year":"2013","journal-title":"Am J Pathol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082242","article-title":"Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome","volume":"206","author":"Briot","year":"2009","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1998.00528.x","article-title":"Immunolocalization of protease-activated receptor-2 in skin: receptor activation stimulates interleukin-8 secretion by keratinocytes in vitro","volume":"94","author":"Hou","year":"1998","journal-title":"Immunology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.2004.00133.x","article-title":"The expression and activation of protease-activated receptor-2 correlate with skin color","volume":"17","author":"Babiarz-Magee","year":"2004","journal-title":"Pigment Cell Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/tra.12843","article-title":"Melanocore uptake by keratinocytes occurs through phagocytosis and involves protease-activated receptor-2 internalization","volume":"23","author":"Moreiras","year":"2022","journal-title":"Traffic"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12982","article-title":"PAR-2 is involved in melanogenesis by mediating stem cell factor production in keratinocytes","volume":"25","author":"Kim","year":"2016","journal-title":"Exp Dermatol"},{"key":"B53","article-title":"Differential regulation of human keratinocyte growth and differentiation by a novel family of protease-activated receptors","volume":"8","author":"Derian","year":"1997","journal-title":"Cell Growth Differ"},{"key":"B54","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jaci.2018.01.007","article-title":"Activation of protease-activated receptor 2 leads to impairment of keratinocyte tight junction integrity","volume":"142","author":"Nadeau","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.168","article-title":"Proteolytically active allergens cause barrier breakdown","volume":"128","author":"Roelandt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41232-024-00338-1","article-title":"Par2-mediated responses in inflammation and regeneration: choosing between repair and damage","volume":"44","author":"Reches","year":"2024","journal-title":"Inflammation Regener"},{"key":"B57","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s41232-022-00238-2","article-title":"Resolving the conflicts around Par2 opposing roles in regeneration by comparing immune-mediated and toxic-induced injuries","volume":"42","author":"Reches","year":"2022","journal-title":"Inflammation Regener"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116622","article-title":"Controlling autoimmune diabetes onset by targeting Protease-Activated Receptor 2","volume":"175","author":"Reches","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/10520290009064152","article-title":"Localization of protease-activated receptors-1 and -2 in human mast cells: indications for an amplified mast cell degranulation cascade","volume":"75","author":"D\u2019Andrea","year":"2000","journal-title":"Biotech Histochem"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700169","article-title":"Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells","volume":"126","author":"Moormann","year":"2006","journal-title":"J Invest Dermatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.01.029","article-title":"Mast cells instruct keratinocytes to produce thymic stromal lymphopoietin: Relevance of the tryptase\/protease-activated receptor 2 axis","volume":"149","author":"Redhu","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18823","article-title":"Mast cell protease\/protease-activated receptor-2 axis: Another mechanism of pigmentation in cutaneous lesions of mastocytosis","volume":"37","author":"Hashimoto","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0702351","article-title":"Expression of and functional responses to protease-activated receptors on human eosinophils","volume":"74","author":"Bolton","year":"2003","journal-title":"J Leukoc Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"21637","DOI":"10.1038\/s41598-023-48365-1","article-title":"Platelet-activating factor and protease-activated receptor 2 cooperate to promote neutrophil recruitment and lung inflammation through nuclear factor-kappa B transactivation","volume":"13","author":"Silva","year":"2023","journal-title":"Sci Rep"},{"key":"B65","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cbi.2019.03.001","article-title":"Protease activated receptor-2 mediated upregulation of IL-17 receptor signaling on airway epithelial cells is responsible for neutrophilic infiltration during acute exposure of house dust mite allergens in mice","volume":"304","author":"Nadeem","year":"2019","journal-title":"Chem Biol Interact"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0108001","article-title":"Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity","volume":"83","author":"Shpacovitch","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2174\/1389450117666151209115232","article-title":"Protease-activated receptor 2: are common functions in glial and immune cells linked to inflammation-related CNS disorders","volume":"17","author":"Bushell","year":"2016","journal-title":"Curr Drug Targets"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706905","article-title":"Activation of mouse protease-activated receptor-2 induces lymphocyte adhesion and generation of reactive oxygen species","volume":"149","author":"Lim","year":"2006","journal-title":"Br J Pharmacol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2005.07.003","article-title":"Protease-activated receptor 2 expression in trigeminal neurons innervating the rat nasal mucosa","volume":"39","author":"Dinh","year":"2005","journal-title":"Neuropeptides"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00142.x","article-title":"Acute effects of substance P and calcitonin gene-related peptide in human skin\u2013a microdialysis study","volume":"115","author":"Weidner","year":"2000","journal-title":"J Invest Dermatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5679-03.2004","article-title":"Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia","volume":"24","author":"Amadesi","year":"2004","journal-title":"J Neurosci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.2011.060764","article-title":"House dust mite potentiates capsaicin-evoked Ca2+ transients in mouse pulmonary sensory neurons via activation of protease-activated receptor-2","volume":"97","author":"Gu","year":"2012","journal-title":"Exp Physiol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/89945","article-title":"Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway","volume":"7","author":"Vergnolle","year":"2001","journal-title":"Nat Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e137393","DOI":"10.1172\/jci.insight.137393","article-title":"The cellular basis of protease-activated receptor 2-evoked mechanical and affective pain","volume":"5","author":"Hassler","year":"2020","journal-title":"JCI Insight"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.152256","article-title":"Scratching behavior and Fos expression in superficial dorsal horn elicited by protease-activated receptor agonists and other itch mediators in mice","volume":"329","author":"Akiyama","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.3c00263","article-title":"Low-dose trypsin accelerates wound healing via protease-activated receptor 2","volume":"7","author":"Xiang","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2023911","article-title":"Atopic dermatiti","volume":"384","author":"St\u00e4nder","year":"2021","journal-title":"N Engl J Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/all.15288","article-title":"Prevalence, atopic and psychological comorbidity of physician-diagnosed atopic dermatitis in an adult general population sample: A cross-sectional study","volume":"77","author":"Piontek","year":"2022","journal-title":"Allergy"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.03.013","article-title":"Neuroimmune\u2002interactions\u2002in\u2002atopic\u2002and\u2002allergic\u2002contact\u2002dermatitis","volume":"151","author":"Liu","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2022.06.004","article-title":"Aberrant serine protease activities in atopic dermatitis","volume":"107","author":"Morizane","year":"2022","journal-title":"J Dermatol Sci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/dds243","article-title":"The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis","volume":"21","author":"Fortugno","year":"2012","journal-title":"Hum Mol Genet"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/all.14018","article-title":"Exonic t lympho-epithelial Kazal-type related inhibitor action and enhance its degradation","volume":"75","author":"Ramesh","year":"2020","journal-title":"Allergy"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2010.51.6.80","article-title":"Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis","volume":"51","author":"Lee","year":"2010","journal-title":"Yonsei Med J"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17940","article-title":"Thymic stromal lymphopoietin production induced by skin irritation results from concomitant activation of protease-activated receptor 2 and interleukin 1 pathways","volume":"182","author":"Redhu","year":"2020","journal-title":"Br J Dermatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01740","article-title":"Protease-activated receptor-2 regulates neuro-epidermal communication in atopic dermatitis","volume":"11","author":"Buhl","year":"2020","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-15-06176.2003","article-title":"Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin","volume":"23","author":"Steinhoff","year":"2003","journal-title":"J Neurosci"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14030","article-title":"House dust mite-treated PAR2 over-expressor mouse: A novel model of atopic dermatitis","volume":"28","author":"Smith","year":"2019","journal-title":"Exp Dermatol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.13","article-title":"Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery","volume":"128","author":"Jeong","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2015.11.011","article-title":"Combined benefits of a PAR2 inhibitor and stratum corneum acidification for murine atopic dermatitis","volume":"136","author":"Sakai","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.08.019","article-title":"PAR2 pepducin-based suppression of inflammation and itch in atopic dermatitis models","volume":"139","author":"Barr","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14201","article-title":"Topical doxycycline monohydrate hydrogel 1% targeting proteases\/PAR2 pathway is a novel therapeutic for atopic dermatitis","volume":"29","author":"Bohannon","year":"2020","journal-title":"Exp Dermatol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e13404","DOI":"10.1111\/srt.13404","article-title":"Research progress on the neutrophil components and their interactions with immune cells in the development of psoriasis","volume":"29","author":"Wang","year":"2023","journal-title":"Skin Res Technol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.22415.x","article-title":"Human airway trypsin-like protease induces PAR-2-mediated IL-8 release in psoriasis vulgaris","volume":"122","author":"Iwakiri","year":"2004","journal-title":"J Invest Dermatol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2009.00998.x","article-title":"Increased mast cell expression of PAR-2 in skin inflammatory diseases and release of IL-8 upon PAR-2 activation","volume":"19","author":"Carvalho","year":"2010","journal-title":"Exp Dermatol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"adv4463","DOI":"10.2340\/actadv.v103.4463","article-title":"Neuroimmune mediators of pruritus in hispanic scalp psoriatic itch","volume":"103","author":"Nattkemper","year":"2023","journal-title":"Acta Derm Venereol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12464","article-title":"Decreased level of PAR2 in Psoriasis and MF patients receiving Phototherapy","volume":"35","author":"Abdel Raheem","year":"2019","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.01.031","article-title":"The ethics of depigmentation for vitiligo","volume":"29","author":"Rau","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1072837","article-title":"Beyond skin white spots: Vitiligo and associated comorbidities","volume":"10","author":"Hu","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3390\/cells12060936","article-title":"The role of oxidative stress in vitiligo: an update on its pathogenesis and therapeutic implications","volume":"12","author":"Chang","year":"2023","journal-title":"Cells"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2009.00562.x","article-title":"Protease-activated receptor-2 downregulation is associated to vitiligo lesions","volume":"22","author":"Moretti","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jdermsci.2013.11.010","article-title":"Protease-activated receptor-2 activates NQO-1 via Nrf2 stabilization in keratinocytes","volume":"74","author":"Kim","year":"2014","journal-title":"J Dermatol Sci"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.5807","article-title":"The effects of phototherapy and melanocytes on keratinocytes","volume":"15","author":"Tang","year":"2018","journal-title":"Exp Ther Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00779-x","article-title":"Update on melasma-part I: pathogenesis","volume":"12","author":"Esp\u00f3sito","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13183","article-title":"Upregulation of protease-activated receptor-2 in keratinocytes by epidermal vascular endothelial growth factor in vitro and in vivo","volume":"26","author":"Lee","year":"2017","journal-title":"Exp Dermatol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12111969","article-title":"Oxidative stress induces skin pigmentation in melasma by inhibiting hedgehog signaling","volume":"12","author":"Kim","year":"2023","journal-title":"Antioxid (Basel)"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01575.x","article-title":"Protease-activated receptor 2, a receptor involved in melanosome transfer, is upregulated in human skin by ultraviolet irradiation","volume":"117","author":"Scott","year":"2001","journal-title":"J Invest Dermatol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1038\/s41467-023-39761-2","article-title":"Whole genome sequencing identifies genetic variants associated with neurogenic inflammation in rosacea","volume":"14","author":"Deng","year":"2023","journal-title":"Nat Commun"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.04.024","article-title":"Cathelicidin LL-37 ignites primed NLRP3 inflammasomes in rosacea","volume":"141","author":"Croitoru","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2014.55.6.1648","article-title":"Increased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea","volume":"55","author":"Kim","year":"2014","journal-title":"Yonsei Med J"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.5021\/ad.21.223","article-title":"The effect of capsaicin on neuroinflammatory mediators of rosacea","volume":"34","author":"Kim","year":"2022","journal-title":"Ann Dermatol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.151","article-title":"Expression of protease-activated receptor-2 in SZ95 sebocytes and its role in sebaceous lipogenesis, inflammation, and innate immunity","volume":"135","author":"Lee","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1001\/jamadermatol.2020.5639","article-title":"Allergic contact dermatitis","volume":"157","author":"Adler","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15894","article-title":"Protease- and cell type-specific activation of protease-activated receptor 2 in cutaneous inflammation","volume":"20","author":"Fleischer","year":"2022","journal-title":"J Thromb Haemost"},{"key":"B114","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1056\/NEJMicm2033425","article-title":"Dermatomyositis","volume":"384","author":"O\u2019Connell","year":"2021","journal-title":"N Engl J Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.biopha.2017.07.088","article-title":"The role and mechanism of cathepsin G in dermatomyositis","volume":"94","author":"Gao","year":"2017","journal-title":"BioMed Pharmacother"},{"key":"B116","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12964-023-01451-3","article-title":"Exosomes in skin photoaging: biological functions and therapeutic opportunity","volume":"22","author":"Hajialiasgary Najafabadi","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102022","article-title":"Protease-activated receptor 2 induces ROS-mediated inflammation through Akt-mediated NF-\u03baB and FoxO6 modulation during skin photoaging","volume":"44","author":"Bang","year":"2021","journal-title":"Redox Biol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17334","article-title":"Scabies itch: an update on neuroimmune interactions and novel targets","volume":"35","author":"Kim","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179935","article-title":"Critical players and therapeutic targets in chronic itch","volume":"23","author":"Yang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.01.012","article-title":"PAR2 mediates itch via TRPV3 signaling in keratinocytes","volume":"140","author":"Zhao","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112425","article-title":"TRPV3 channel in keratinocytes in scars with post-burn pruritus","volume":"18","author":"Park","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.09.032","article-title":"Non-histaminergic itch mediators elevated in the skin of a porcine model of scabies and of human scabies patients","volume":"139","author":"Sanders","year":"2019","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1449126\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:30:54Z","timestamp":1726705854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1449126\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":122,"alternative-id":["10.3389\/fimmu.2024.1449126"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1449126","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"article-number":"1449126"}}